Newest
BETR ▼ sold $13K · Tuffin Paula filed 2d agoBETR ▼ sold $14K · Nicholas J. Calamari filed 2d agoFBK ▲ bought $716K · INGRAM ORRIN H II filed 2d agoFBK ▲ bought $821K · INGRAM ORRIN H II filed 2d agoBEN ▼ sold $5.0M · FRANKLIN TEMPLETON INC filed 2d agoNAD ▼ sold $338K · Robert Young L filed 3d agoWSBC ▼ sold $15K · Rep. Michael A. Rulli filed 4d agoGOOG ▼ sold $100K · Rep. Michael A. Rulli filed 4d agoWMT ▼ sold $100K · Rep. Jonathan L. Jackson filed 4d agoVSAT ▼ sold $100K · Rep. Jonathan L. Jackson filed 4d agoTYG ▼ sold $15K · Rep. Jonathan L. Jackson filed 4d agoGH ▲ bought $50K · Rep. Jonathan L. Jackson filed 4d agoEL ▲ bought $100K · Rep. Jonathan L. Jackson filed 4d agoDDOG ▲ bought $100K · Rep. Jonathan L. Jackson filed 4d agoCPRT ▼ sold $553K · Morefield Diane M filed 4d agoPTON ▼ sold $154K · Kirol Charles Peter filed 4d agoEME ▲ bought $1K · MCEVOY M KEVIN filed 4d agoEME ▲ bought $826 · MCEVOY M KEVIN filed 4d ago

Stock / equity

BCYC BICYCLE THERAPEUTICS PLC

Company
BICYCLE THERAPEUTICS PLC
Security
Equity
Size, estimated from filings
Micro cap (under $300M)
Insiders on record
18
Latest trade on record
October 5, 2026

BCYC (BICYCLE THERAPEUTICS PLC) has 84 disclosed insider transactions from 16 insiders in the last 12 months (0 open-market buys, 47 sales, about $521K at reported prices) and 0 congressional trades from 0 members of Congress. The most recent disclosure was filed October 6, 2026.

Last updated October 6, 2026 · Sources: SEC EDGAR Form 4; House Clerk and Senate eFD PTRs

Insider txns (12m)
84
Open-market buys / sales
0 / 47
Congress trades (12m)
0
Distinct filers (12m)
16

Share price

Price and chart by TradingView for BICYCLE THERAPEUTICS PLC. US share prices here are delayed, not real-time. The trade records on this page come from government filings, not from this chart.

BCYC in charts

Who is trading this stock

Which people account for the buying and selling over the last 12 months?

BoughtSold

8 people account for the disclosed buying and selling in BCYC over the last 12 months; the most active is Lee Kevin with $239K.

Embed this chart
<iframe src="https://spotthemoney.com/embed/stocks/bcyc/" width="640" height="360" loading="lazy" style="border:0;max-width:100%" title="Who is trading BCYC — Spot the Money"></iframe>
<p>Source: <a href="https://spotthemoney.com/stocks/bcyc/">Spot the Money</a></p>

Prices insiders traded at

What price did insiders buy and sell at? Each marker is one open-market trade at the share price reported on its Form 4.

▲ Bought▼ SoldAverage reported price that day
$0$5$10Oct 2025Oct 2026
$0$5$10Oct 2025Oct 2026

Insiders reported 60 open-market trades in BCYC since Oct 2, 2025, at prices from $3.47 to $8.61; the most recent was a sale at $3.57 on Oct 5, 2026. These are the prices on the filings, not adjusted for stock splits, and not a market price series.

Insider holdings over time

Is an insider building or unwinding a position? Shares held directly after each filing.

Thompson Travis AlvinLee Kevin
0309K619K64K596K2025-10-062026-10-06

Thompson Travis Alvin reported 64,449 shares held after the latest filing, against 31,197 at the first on record.

Lobbying spend by quarter

How much has BICYCLE THERAPEUTICS PLC reported spending on federal lobbying?

Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26
Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26

BICYCLE THERAPEUTICS PLC reported $450K in lobbying over the last eight quarters, from filings matched by exact company name.

Insiders trading BCYC

Everyone who filed a Form 4 for this ticker, by number of rows on record. "Bought" and "sold" count open-market purchases (code P) and sales only; awards, option exercises and shares withheld for tax are in the row count but not in those two columns. Showing 15 of 18.

InsiderRoleRowsBoughtSoldValue boughtValue soldLatest
Thompson Travis AlvinChief Financial Officer14010—$31KOctober 5, 2026
Hannay Michael Charles FergusonCHIEF PROD & SUPPLY CHAIN OFF13010—$63KOctober 5, 2026
Skynner MichaelCHIEF SCIENTIFIC OFFICER13010—$88KOctober 5, 2026
Lee KevinCHIEF EXECUTIVE OFFICER12010—$285KOctober 5, 2026
Perry Jennifer ScottChief Operating Officer1009—$18KOctober 5, 2026
Young AlethiaChief Financial Officer705—$55KJanuary 5, 2026
Novartis Bioventures LtdInsider710$2.4M—May 28, 2019
Milnes AlistairCHIEF OPERATING OFFICER604—$62KJanuary 5, 2026
Swanton Robert CharlesDirector402—$13KOctober 2, 2026
BAKER BROS. ADVISORS LPDirector400——January 2, 2026
GLAXOSMITHKLINE PLCInsider303—$92KJuly 15, 2020
Bourque JaniceDirector200——January 2, 2026
DANSEY ROGER DDirector200——January 2, 2026
Gutierrez-Ramos Jose-CarlosSVP, Chief Science Officer200——January 2, 2026
Hoppenot HerveDirector200——January 2, 2026
What kind of transactions these are 5 Form 4 codes
CodeMeaningRowsSharesValue at reported prices
SOpen-market sale63111,594$706K
AGrant or award371,785,014—
CConversion of a derivative43,059,122—
XExercise of an in-the-money option2142,900—
POpen-market purchase1168,630$2.4M

What each code means: Form 4 transaction codes.

Download CSV107 rows · 37 KB · insider and congressional rows for this ticker · all downloads

Insider transactions

FilerSideTrade dateDisclosedLagSharesPriceValueFlagsSourceShare
Thompson Travis AlvinSell SOctober 5, 2026October 6, 20261d79$4$282Form 4 ↗
Thompson Travis AlvinSell SOctober 2, 2026October 6, 20264d893$3$3,099Form 4 ↗
Lee KevinSell SOctober 5, 2026October 6, 20261d1,638$4$5,848Form 4 ↗
Lee KevinSell SOctober 2, 2026October 6, 20264d6,167$3$21KForm 4 ↗
Perry Jennifer ScottSell SOctober 5, 2026October 6, 20261d326$4$1,23210b5-1 planForm 4 ↗
Perry Jennifer ScottSell SOctober 5, 2026October 6, 20261d80$4$28510b5-1 planForm 4 ↗
Perry Jennifer ScottSell SOctober 2, 2026October 6, 20264d1,094$3$3,79610b5-1 planForm 4 ↗
Hannay Michael Charles FergusonSell SOctober 5, 2026October 6, 20261d242$4$864Form 4 ↗
Hannay Michael Charles FergusonSell SOctober 2, 2026October 6, 20264d1,572$3$5,455Form 4 ↗
Skynner MichaelSell SOctober 5, 2026October 6, 20261d503$4$1,796Form 4 ↗
Skynner MichaelSell SOctober 2, 2026October 6, 20264d1,942$3$6,739Form 4 ↗
Swanton Robert CharlesSell SOctober 2, 2026October 6, 20264d3,431$3$12KForm 4 ↗
Perry Jennifer ScottOther AJuly 15, 2026July 17, 20262d60,000——derivativeForm 4 ↗
Skynner MichaelOther AJuly 15, 2026July 17, 20262d60,000——derivativeForm 4 ↗
Hannay Michael Charles FergusonOther AJuly 15, 2026July 17, 20262d60,000——derivativeForm 4 ↗
Thompson Travis AlvinOther AJuly 15, 2026July 17, 20262d60,000——derivativeForm 4 ↗
Thompson Travis AlvinSell SJuly 6, 2026July 7, 20261d104$4$448Form 4 ↗
Thompson Travis AlvinSell SJuly 2, 2026July 7, 20265d819$4$3,497lateForm 4 ↗
Hannay Michael Charles FergusonSell SJuly 6, 2026July 7, 20261d255$4$1,099Form 4 ↗
Hannay Michael Charles FergusonSell SJuly 2, 2026July 7, 20265d1,506$4$6,431lateForm 4 ↗
Lee KevinSell SJuly 6, 2026July 7, 20261d1,737$4$7,486Form 4 ↗
Lee KevinSell SJuly 2, 2026July 7, 20265d5,905$4$25KlateForm 4 ↗
Skynner MichaelSell SJuly 6, 2026July 7, 20261d532$4$2,293Form 4 ↗
Skynner MichaelSell SJuly 2, 2026July 7, 20265d1,859$4$7,938lateForm 4 ↗
Perry Jennifer ScottSell SJuly 6, 2026July 7, 20261d333$4$1,44510b5-1 planForm 4 ↗
Perry Jennifer ScottSell SJuly 6, 2026July 7, 20261d43$4$18510b5-1 planForm 4 ↗
Perry Jennifer ScottSell SJuly 2, 2026July 7, 20265d1,036$4$4,424late10b5-1 planForm 4 ↗
Thompson Travis AlvinSell SApril 6, 2026April 6, 20260d102$5$515Form 4 ↗
Thompson Travis AlvinSell SApril 2, 2026April 6, 20264d799$5$3,923Form 4 ↗
Perry Jennifer ScottSell SApril 6, 2026April 6, 20260d333$5$1,67810b5-1 planForm 4 ↗
Perry Jennifer ScottSell SApril 6, 2026April 6, 20260d37$5$18710b5-1 planForm 4 ↗
Perry Jennifer ScottSell SApril 2, 2026April 6, 20264d1,038$5$5,09710b5-1 planForm 4 ↗
Lee KevinSell SApril 6, 2026April 6, 20260d1,716$5$8,666Form 4 ↗
Lee KevinSell SApril 2, 2026April 6, 20264d5,967$5$29KForm 4 ↗
Skynner MichaelSell SApril 6, 2026April 6, 20260d525$5$2,651Form 4 ↗
Skynner MichaelSell SApril 2, 2026April 6, 20264d1,879$5$9,226Form 4 ↗
Hannay Michael Charles FergusonSell SApril 6, 2026April 6, 20260d251$5$1,268Form 4 ↗
Hannay Michael Charles FergusonSell SApril 2, 2026April 6, 20264d1,521$5$7,468Form 4 ↗
Thompson Travis AlvinOther AFebruary 3, 2026February 4, 20261d58,000——derivativeForm 4 ↗
Thompson Travis AlvinOther AJanuary 2, 2026January 6, 20264d75,000——derivativeForm 4 ↗
Thompson Travis AlvinSell SJanuary 5, 2026January 6, 20261d1,115$6$7,192Form 4 ↗
Thompson Travis AlvinSell SJanuary 2, 2026January 6, 20264d1,317$7$8,956Form 4 ↗
Thompson Travis AlvinOther AJanuary 2, 2026January 6, 20264d37,500——Form 4 ↗
Skynner MichaelOther AJanuary 2, 2026January 6, 20264d100,000——derivativeForm 4 ↗
Skynner MichaelSell SJanuary 5, 2026January 6, 20261d3,266$6$21KForm 4 ↗
Skynner MichaelSell SJanuary 2, 2026January 6, 20264d3,045$7$21KForm 4 ↗
Skynner MichaelOther AJanuary 2, 2026January 6, 20264d50,000——Form 4 ↗
Hannay Michael Charles FergusonOther AJanuary 2, 2026January 6, 20264d100,000——derivativeForm 4 ↗
Hannay Michael Charles FergusonSell SJanuary 5, 2026January 6, 20261d2,367$6$15KForm 4 ↗
Hannay Michael Charles FergusonSell SJanuary 2, 2026January 6, 20264d2,827$7$19KForm 4 ↗
Hannay Michael Charles FergusonOther AJanuary 2, 2026January 6, 20264d50,000——Form 4 ↗
Milnes AlistairOther AJanuary 2, 2026January 6, 20264d100,000——derivativeForm 4 ↗
Milnes AlistairSell SJanuary 5, 2026January 6, 20261d3,416$6$22KForm 4 ↗
Milnes AlistairSell SJanuary 2, 2026January 6, 20264d3,244$7$22KForm 4 ↗
Milnes AlistairOther AJanuary 2, 2026January 6, 20264d50,000——Form 4 ↗
Young AlethiaOther AJanuary 2, 2026January 6, 20264d100,000——10b5-1 planderivativeForm 4 ↗
Young AlethiaSell SJanuary 5, 2026January 6, 20261d1,878$7$12K10b5-1 planForm 4 ↗
Young AlethiaSell SJanuary 5, 2026January 6, 20261d2,456$6$16K10b5-1 planForm 4 ↗
Young AlethiaSell SJanuary 2, 2026January 6, 20264d3,289$7$22K10b5-1 planForm 4 ↗
Young AlethiaOther AJanuary 2, 2026January 6, 20264d50,000——10b5-1 planForm 4 ↗
Lee KevinOther AJanuary 2, 2026January 6, 20264d330,000——derivativeForm 4 ↗
Lee KevinSell SJanuary 5, 2026January 6, 20261d10,989$6$71KForm 4 ↗
Lee KevinSell SJanuary 2, 2026January 6, 20264d10,325$7$70KForm 4 ↗
Lee KevinOther AJanuary 2, 2026January 6, 20264d165,000——Form 4 ↗
Sands Stephen H.Other AJanuary 2, 2026January 6, 20264d19,000——derivativeForm 4 ↗
Sands Stephen H.Other AJanuary 2, 2026January 6, 20264d9,500——Form 4 ↗
Riva AlessandroOther AJanuary 2, 2026January 6, 20264d14,761——derivativeForm 4 ↗
Riva AlessandroOther AJanuary 2, 2026January 6, 20264d7,380——Form 4 ↗
DANSEY ROGER DOther AJanuary 2, 2026January 6, 20264d6,065——derivativeForm 4 ↗
DANSEY ROGER DOther AJanuary 2, 2026January 6, 20264d3,032——Form 4 ↗
Winter Gregory PaulOther AJanuary 2, 2026January 6, 20264d19,000——derivativeForm 4 ↗
Winter Gregory PaulOther AJanuary 2, 2026January 6, 20264d9,500——Form 4 ↗
Hoppenot HerveOther AJanuary 2, 2026January 6, 20264d6,065——derivativeForm 4 ↗
Hoppenot HerveOther AJanuary 2, 2026January 6, 20264d3,032——Form 4 ↗
Bourque JaniceOther AJanuary 2, 2026January 6, 20264d19,000——derivativeForm 4 ↗
Bourque JaniceOther AJanuary 2, 2026January 6, 20264d9,500——Form 4 ↗
Gutierrez-Ramos Jose-CarlosOther AJanuary 2, 2026January 6, 20264d19,000——derivativeForm 4 ↗
Gutierrez-Ramos Jose-CarlosOther AJanuary 2, 2026January 6, 20264d9,500——Form 4 ↗
Swanton Robert CharlesOther AJanuary 2, 2026January 6, 20264d7,453——derivativeForm 4 ↗
Swanton Robert CharlesOther AJanuary 2, 2026January 6, 20264d3,726——Form 4 ↗
BAKER BROS. ADVISORS LPOther AJanuary 2, 2026January 6, 20264d38,000——indirectderivativeForm 4 ↗
BAKER BROS. ADVISORS LPOther AJanuary 2, 2026January 6, 20264d38,000——indirectderivativeForm 4 ↗
BAKER BROS. ADVISORS LPOther AJanuary 2, 2026January 6, 20264d19,000——indirectForm 4 ↗
BAKER BROS. ADVISORS LPOther AJanuary 2, 2026January 6, 20264d19,000——indirectForm 4 ↗
Lee KevinSell SOctober 3, 2025October 6, 20253d3,231$8$27KForm 4 ↗
Lee KevinSell SOctober 2, 2025October 6, 20254d2,263$8$19KForm 4 ↗
Skynner MichaelSell SOctober 3, 2025October 6, 20253d978$8$8,225Form 4 ↗
Skynner MichaelSell SOctober 2, 2025October 6, 20254d824$8$6,922Form 4 ↗
Milnes AlistairSell SOctober 3, 2025October 6, 20253d978$8$8,225Form 4 ↗
Milnes AlistairSell SOctober 2, 2025October 6, 20254d1,147$8$9,635Form 4 ↗
Hannay Michael Charles FergusonSell SOctober 3, 2025October 6, 20253d250$8$2,103Form 4 ↗
Hannay Michael Charles FergusonSell SOctober 2, 2025October 6, 20254d473$8$3,973Form 4 ↗
Young AlethiaSell SOctober 2, 2025October 6, 20254d265$9$2,28010b5-1 planForm 4 ↗
Young AlethiaSell SOctober 2, 2025October 6, 20254d217$8$1,82310b5-1 planForm 4 ↗
Thompson Travis AlvinSell SOctober 3, 2025October 6, 20253d103$8$866Form 4 ↗
Thompson Travis AlvinSell SOctober 2, 2025October 6, 20254d221$8$1,856Form 4 ↗
Swanton Robert CharlesSell SOctober 2, 2025October 6, 20254d102$9$87210b5-1 planForm 4 ↗
GLAXOSMITHKLINE PLCSell SJuly 15, 2020September 18, 202065d78$19$1,502lateindirectForm 4 ↗
GLAXOSMITHKLINE PLCSell SJuly 15, 2020September 18, 202065d3,069$19$60KlateindirectForm 4 ↗
GLAXOSMITHKLINE PLCSell SJuly 14, 2020September 18, 202066d1,597$19$31KlateindirectForm 4 ↗
Novartis Bioventures LtdExchange CMay 28, 2019May 30, 20192d636,366——derivativeForm 4 ↗
Novartis Bioventures LtdOption / conversion XMay 28, 2019May 30, 20192d71,450——derivativeForm 4 ↗
Novartis Bioventures LtdExchange CMay 28, 2019May 30, 20192d893,195——derivativeForm 4 ↗
Novartis Bioventures LtdBuy PMay 28, 2019May 30, 20192d168,630$14$2.4MForm 4 ↗
Novartis Bioventures LtdExchange CMay 28, 2019May 30, 20192d636,366——Form 4 ↗
Novartis Bioventures LtdOption / conversion XMay 28, 2019May 30, 20192d71,450——Form 4 ↗
Novartis Bioventures LtdExchange CMay 28, 2019May 30, 20192d893,195——Form 4 ↗

Congressional trades

No member of Congress has disclosed a trade in this ticker in the filings we have parsed.

Tickers traded by the same people who traded BCYC, by number of filers in common. It shows overlap in public filings and nothing else.

  • DHR Danaher Corporation Common Stock 1 filer in common
  • WVE Wave Life Sciences, Inc. 1 filer in common
  • CVRX CVRx, Inc. 1 filer in common
  • GRTX Galera Therapeutics, Inc. 1 filer in common
  • INVA Innoviva, Inc. 1 filer in common
  • LYEL Lyell Immunopharma, Inc. 1 filer in common
  • DBTX Decibel Therapeutics, Inc. 1 filer in common
  • AKUS Akouos, Inc. 1 filer in common

Guides for this page

Sources and method

Official sources behind this page
SourceFilingsRowsFirst filedNewest filedRead the originals
SEC EDGAR, Form 445107May 30, 2019October 6, 2026Form 4 list on EDGAR

Site built October 22, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.

Insider rows are Form 4 filings for this issuer from SEC EDGAR; congressional rows are periodic transaction reports parsed from the House Clerk and the Senate eFD. Values use the reported price for Form 4 and the disclosed range for Congress. See methodology and corrections.

Not investment advice. Disclosures are shown as filed and may lag the trade or be amended. No recommendation is made or implied.